ADHD and Co-Occurring Conditions: Anxiety, Depression, and Sleep Problems
Attention-deficit/hyperactivity disorder (ADHD) is rarely a standalone condition. For the majority of individuals diagnosed with ADHD, at least one other psychiatric or physical health condition coexists. About two-thirds of people with ADHD have at least one co-occurring condition, such as anxiety, depression, a learning disorder, or a sleep disorder[reference:0]. This is not a coincidence; it reflects shared genetic vulnerabilities, overlapping neurobiological pathways, and the cumulative impact of living with a chronic neurodevelopmental disorder.
Among the most common and clinically significant comorbidities are anxiety disorders, depressive disorders, and sleep problems. These conditions do not merely accompany ADHD—they interact with it, often worsening symptoms, complicating treatment, and reducing quality of life. Understanding the prevalence, mechanisms, and management of these comorbidities is essential for effective clinical care.
Anxiety and ADHD: A Common but Often Overlooked Pairing
Anxiety disorders are among the most frequent comorbidities in ADHD. A 2025 study of 358 adults with ADHD found that the prevalence of comorbid anxiety disorders was 38.1%[reference:1]. Among those with comorbid anxiety, 58.1% were female, consistent with earlier findings that female gender is a significant risk factor[reference:2]. The most common anxiety disorders in this population were generalised anxiety disorder (24%), social phobia (11.1%), specific phobia (8.6%), and panic disorder (3.1%)[reference:3].
Other studies report even higher figures. A 2026 survey of 394 adults with probable ADHD found that 46.8% had anxiety disorders[reference:4]. Population-based studies have confirmed that anxiety disorders affect 25–50% of individuals with ADHD[reference:5]. Among adults with ADHD, about 53% have anxiety[reference:6]. In children, the rate is lower but still substantial: about 30% of children with ADHD also have anxiety[reference:7].
The relationship between ADHD and anxiety is not merely additive. Anxiety can mask ADHD symptoms, leading to under-recognition or misdiagnosis[reference:8]. A person who is chronically anxious may appear inattentive or restless, but these symptoms may be attributed to anxiety rather than to underlying ADHD. Conversely, untreated ADHD can generate significant anxiety—through chronic procrastination, missed deadlines, and social difficulties—making it difficult to determine which condition came first.
Depression and ADHD: A Bidirectional Burden
Depression is another common comorbidity, with rates varying by age and study population. Among adults with ADHD, about 47% also have depression[reference:9]. A 2026 study found that 42.3% of adults with probable ADHD experienced depression, with 38.3% reporting moderate to severe levels[reference:10]. In children and adolescents, a 2025 meta-analysis estimated a pooled depression rate of 11.31%, though individual study rates ranged from 1.7% to 60%[reference:11].
The relationship between ADHD and depression is bidirectional[reference:12]. ADHD symptoms—particularly inattention and executive dysfunction—can lead to academic and occupational failures, social rejection, and chronic stress, all of which increase the risk of depression. Conversely, depression can impair concentration and exacerbate the cognitive symptoms of ADHD[reference:13]. Some evidence suggests that anxiety may precede and drive the emergence of depressive symptoms in youth with ADHD[reference:14].
Depression in the context of ADHD is often more severe and treatment-resistant. A large-scale population-based study found that individuals with ADHD had a pooled odds ratio of 4.5 for major depressive disorder compared to those without ADHD[reference:15]. This elevated risk underscores the importance of routine screening for depression in all individuals with ADHD.
Sleep Problems: The Overlooked Comorbidity
Sleep disturbances are perhaps the most pervasive yet underrecognised comorbidity in ADHD. In children and adolescents, the prevalence of sleep disturbances is estimated at 40–80%[reference:16]. Up to 72% of adolescents with ADHD present with sleep problems[reference:17]. In adults, the figures are similarly striking. A 2024 study of 3,691 adults with ADHD found that about 60% screened positive for at least one sleep disorder[reference:18]. The most common were symptoms of delayed sleep phase syndrome (36%), insomnia (30%), and restless legs syndrome or periodic limb movement disorder (29%)[reference:19].
Sleep problems in ADHD are not merely a consequence of hyperactivity or stimulant medication. They are intrinsically linked to the disorder itself, involving circadian rhythm disruptions, altered sleep architecture, and heightened arousal. A meta-analysis of polysomnographic studies found that sleep alterations were evident in ADHD, though the pattern differed from that seen in other psychiatric disorders[reference:20].
The relationship between sleep and ADHD is complex and bidirectional. Sleep problems predict worse ADHD symptoms, and ADHD symptoms predict worse sleep[reference:21]. Moreover, sleep problems are associated with comorbid depression and anxiety[reference:22]. A study of adolescents found that parent-reported sleep problems were associated not only with ADHD but also with anxiety, depression, and externalising disorders[reference:23]. In children, anxiety contributed to higher overall sleep disturbance scores compared to children with ADHD alone[reference:24].
The Interconnection: How These Conditions Amplify Each Other
Anxiety, depression, and sleep problems do not exist in isolation. They interact with each other and with ADHD in a vicious cycle. Anxiety can make it harder to fall asleep, and sleep deprivation can worsen anxiety and depression. Depression can reduce motivation and energy, making it harder to manage ADHD symptoms. ADHD-related impulsivity and disorganisation can lead to poor sleep hygiene and missed medication doses.
This interconnection has been confirmed in network analyses. One study found that the inattention component of ADHD linked to obsessive thinking, which bridged to anxiety, perfectionism, and feelings of inferiority[reference:25]. Another study found that irritability—a transdiagnostic factor—commonly co-occurs with ADHD, depression, and generalised anxiety disorder[reference:26].
The cumulative impact of these comorbidities is substantial. Adults with ADHD and comorbid anxiety, depression, or sleep problems have higher rates of functional impairment, lower quality of life, and greater treatment resistance. They are also more likely to have a history of suicide attempts[reference:27] and substance use disorders[reference:28].
Sex and Age Differences in Comorbidity Patterns
Comorbidity patterns vary by sex and age. In children, the most common comorbidities are oppositional defiant disorder, conduct disorder, learning disabilities, and tic disorders. In adults, the profile shifts to anxiety, depression, bipolar disorder, and substance use disorders.
Sex differences are also pronounced. Women with ADHD are more likely to have comorbid anxiety and depression[reference:29]. A 2025 study found that 58.1% of adults with ADHD and comorbid anxiety were female[reference:30]. Women with ADHD also have higher rates of perinatal depression, with prevalence estimates ranging from 16.76% to 57.6%[reference:31]. In contrast, men with ADHD may have higher rates of substance use disorders and externalising behaviours.
Age also matters. In children, anxiety and depression rates are lower than in adults, but they increase over time. The transition from adolescence to adulthood is a particularly vulnerable period, as the demands of independent living, work, and relationships can overwhelm previously adequate coping strategies.
Table: Prevalence of Comorbidities in ADHD
| Comorbidity | Children | Adults | Key Studies |
|---|---|---|---|
| Anxiety | ~30%[reference:32] | 38–53%[reference:33][reference:34] | Prevalence and associated factors of anxiety disorders comorbidity in adults with ADHD (2025); CHADD (2026) |
| Depression | ~14%[reference:35] | 38–47%[reference:36][reference:37] | Rates of Depression in Children and Adolescents With ADHD (2025); CHADD (2026) |
| Sleep Disorders | 40–80%[reference:38] | ~60%[reference:39] | Sleep Problems in Adults With ADHD (2024); Meta-analysis of sleep in ADHD (2018) |
| Any Comorbidity | ~66%[reference:40] | ~66%[reference:41] | CHADD (2026); Denmark population study |
Clinical Implications: Diagnosis and Management
The high prevalence of comorbidities in ADHD has several clinical implications. First, diagnostic assessment must be comprehensive. Clinicians should routinely screen for anxiety, depression, and sleep problems in all individuals with ADHD. Conversely, individuals presenting with anxiety, depression, or sleep problems should be screened for underlying ADHD, particularly if they report a lifelong pattern of inattention or impulsivity.
Second, treatment must be integrated. Treating ADHD in isolation is unlikely to be effective if comorbid conditions are left unaddressed. Conversely, treating anxiety or depression without addressing ADHD may yield only partial improvement. A combined approach—addressing both ADHD and comorbidities—is recommended[reference:42].
Third, medication management requires careful consideration. Stimulants can worsen anxiety or insomnia in some individuals, while they may improve sleep in others by reducing hyperactivity and mental restlessness[reference:43]. Non-stimulant options, such as atomoxetine or guanfacine, may be preferred in individuals with significant anxiety or sleep problems. Antidepressants, particularly SSRIs, can be used for comorbid depression or anxiety, but they may not address core ADHD symptoms.
Fourth, non-pharmacological interventions are essential. Cognitive-behavioural therapy (CBT) is effective for anxiety and depression and can be adapted for ADHD[reference:44]. Sleep hygiene interventions, including melatonin (0.5 mg taken 3 hours before bedtime), can help regulate circadian rhythm[reference:45]. Behavioural interventions targeting executive dysfunction, time management, and emotional regulation can also reduce the burden of comorbidities.
Finally, the bidirectional nature of these conditions means that improvement in one area can lead to improvement in others. Treating sleep problems may reduce anxiety and depression. Treating anxiety may improve sleep and reduce ADHD symptoms. This interconnectedness offers opportunities for integrated, holistic care.
Emerging Research: Shared Neurobiological Mechanisms
Recent research has begun to uncover the shared neurobiological mechanisms underlying ADHD and its comorbidities. A comprehensive review led by Dr. Stephen V. Faraone and colleagues explored how serotonin (5-HT) may be at the heart of many common comorbidities[reference:46]. Serotonin dysregulation has been implicated in ADHD, anxiety, depression, and sleep disorders, suggesting a common pathway[reference:47].
Genetic studies also support shared vulnerability. A GWAS meta-analysis has examined the genetic and regulatory mechanisms of comorbidity between anxiety, depression, and ADHD[reference:48]. These findings suggest that the co-occurrence of these conditions is not merely coincidental but reflects overlapping genetic and neurobiological factors.
This research has important implications for treatment. If serotonin dysregulation is a common pathway, then medications targeting serotonin—such as SSRIs—may have benefits beyond their primary indications. Similarly, interventions that improve sleep or reduce anxiety may have downstream effects on ADHD symptoms.
Conclusion
ADHD is rarely a standalone condition. Anxiety, depression, and sleep problems are common comorbidities that significantly affect the course, treatment, and outcomes of ADHD. The relationships between these conditions are bidirectional and interconnected, creating a complex clinical picture that requires comprehensive assessment and integrated treatment.
Clinicians must be vigilant in screening for comorbidities, and patients should be educated about the high prevalence of these conditions. Effective management requires a holistic approach that addresses ADHD and its comorbidities simultaneously, using a combination of pharmacotherapy, psychotherapy, and lifestyle interventions. With appropriate care, individuals with ADHD and comorbid conditions can achieve significant improvement in symptoms and quality of life.
References
- Prevalence and associated factors of anxiety disorders comorbidity in adults with ADHD. (2025). ScienceDirect. https://www.sciencedirect.com/science/article/pii/S2772408525007884
- Romo L, Getin C, Weibel S, et al. (2026). Impact of psychopathological dimensions on functional impairments in adults with probable ADHD. International Journal of Mental Health, 55(1), 133. doi:10.1080/00207411.2025.2592165
- van der Ham M, Bijlenga D, Böhmer M, et al. (2024). Sleep Problems in Adults With ADHD: Prevalences and Their Relationship With Psychiatric Comorbidity. Journal of Attention Disorders, 28(13), 1642-1652. https://pure.amsterdamumc.nl/en/publications/sleep-problems-in-adults-with-adhd-prevalences-and-their-relation/
- CHADD. (2026). ADHD Often Comes with Another Condition. https://chadd.org/adhd-news/adhd-news-caregivers/adhd-weekly-adhd-often-comes-with-another-condition/
- Loram G, et al. (2024). Examining the associations between attention-deficit/hyperactivity disorder, sleep problems, and other mental health conditions in adolescents. J Sleep Res, 33(2), e13830. PMID: 36907830
- Accardo JA, et al. (2012). Associations between psychiatric comorbidities and sleep disturbances in children with attention-deficit/hyperactivity disorder. J Dev Behav Pediatr, 33(2), 97-105. PMID: 22261833
- Rates of Depression in Children and Adolescents With ADHD: A Systematic Review and Meta-Analysis. (2025). Journal of Attention Disorders. https://www.research.ed.ac.uk
- Faraone SV, Ward CL, Boucher M, et al. Role of serotonin in psychiatric and somatic comorbidities of attention-deficit/hyperactivity disorder. ADHD Evidence Project. https://adhdevidence.net
- Hartman CA, Larsson H, et al. (2023). Anxiety, mood, and substance use disorders in adult men and women with and without attention-deficit/hyperactivity disorder: A substantive and methodological overview. Neuroscience and Biobehavioral Reviews, 151, 105209. doi:10.1016/j.neubiorev.2023.105209
This article is for informational purposes only and does not constitute medical advice. ADHD, anxiety, depression, and sleep disorders are complex conditions that require professional assessment and diagnosis. If you or someone you know is experiencing symptoms, please consult a qualified healthcare provider. Never start, stop, or change medication without medical supervision.
